Emmys to be postponed because of writer and actor strikes
Striking screenwriters were joined this month by actors and others represented by SAG-AFTRA after contract negotiations failed.
This regional bank could soon become a ‘massive market share taker,’ JPMorgan says
JPMorgan upgraded shares to overweight in its first time since it began covering the stock.
New research on Facebook shows the algorithm isn’t entirely to blame for political polarization
Researchers working with Meta published four new studies that detail a nuanced view of polarization on Facebook and Instagram.
Trump hit with new charges in classified documents case, third defendant added
Carlos Deoliveira joins former President Donald Trump and valet Walt Nauta as defendants in the case involving classified documents at Mar-a-Lago in Florida.
Sweetgreen shares tumble after salad chain reports weak sales but narrowing losses
Sweetgreen, which went public in November 2021, is aiming to turn a profit for the first time by 2024.
Airlines say domestic fares are sliding and threatening to chill record revenue growth
Southwest Airlines, Alaska Airlines and American Airlines have forecast weaker fare growth.
SpaceX came close to breaking a 56-year rocket record with back-to-back launches
SpaceX was set to launch a Falcon 9 rocket and then a Falcon Heavy rocket from Florida as little as 45 minutes apart on Thursday evening.
Ford raises full-year guidance after solid earnings beat
There was pressure on Ford to raise its guidance after crosstown rival General Motors raised its yearly guidance Tuesday for the second time this year.
Microsoft responsible for China’s U.S. government email hack, Senator Wyden says
Chinese hackers accessed the Microsoft-powered email accounts of top China envoys, Commerce Secretary Gina Raimondo, and Secretary of State Antony Blinken.
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
The data bolsters Eli Lilly’s position in the budding weight loss drug market and establishes the company as a formidable competitor to Novo Nordisk.
